The proceedings contain 20 papers. The topics discussed include: genetic ablation or pharmacological inhibition of cell cycle pathways provides neuroprotection in experimental TBI; combined inhibition of caspase-dependent and caspase-independent cell death pathways affords additive neuroprotection after experimental traumatic brain injury; inhibition of nitric oxide synthase augmented anti-depressant like effects of estradiol in ovariectomized mice: a new strategy for treatment of depression; comparing the predictive value of multiple cognitive and motor tasks after rodent TBI; role of cell cycle in experimental spinal cord injury: delayed treatment with a pan-CDK inhibitor is protective; cost-effective use of biomarkers for neurotherapeutic agents: quantitative estimates from historical data; scientific and economic benefits of sequential parallel comparative design (SPCD), a novel clinical trial methodology; and characterizing radiology reports in patients with Alzheimer's disease.
CITATION STYLE
Clarence-Smith, K. (2015). Abstracts from the ASENT 17th Annual Meeting. Neurotherapeutics, 12(3), 678–687. https://doi.org/10.1007/s13311-015-0362-x
Mendeley helps you to discover research relevant for your work.